Perth-based biotechnology company pSivida Ltd has commenced enrolment for the first studies of absorption, distribution and metabolism of its diabetic macular edema treatment Medidur, the company has announced.
22/08/2007 - 12:48
pSivida opens enrolments for macular edema treatment trials
22/08/2007 - 12:48
